Statement from the Chief Public Health Officer of Canada on April 5, 2021

Statement

April 5, 2021 | Ottawa, ON | Public Health Agency of Canada

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks. Through the Wellness Together Canada online portal, people of all ages across the country can access immediate, free and confidential mental health and substance use supports, 24 hours a day, seven days a week.

As COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity. At the same time, the Public Health Agency of Canada is providing Canadians with regular updates on COVID-19 vaccines administered, vaccination coverage and ongoing monitoring of vaccine safety across the country. The following is the latest summary on national numbers and trends, and the actions we all need to be taking to reduce infection rates, while vaccination programs expand for the protection of all Canadians. Due to reduced reporting over the holidays, national seven-day averages have not been updated in today's statement. These data are still being collected and analysed. I will provide the latest numbers during my remarks tomorrow.

Since the start of the pandemic, there have been 1,000,545 cases of COVID-19, including 56,036 active cases and 23,050 deaths reported in Canada; these cumulative numbers tell us about the overall burden of COVID-19 illness to date. They also tell us, together with results of serological studies, that the vast majority of Canadians remain susceptible to COVID-19. As vaccine delivery ramps up at an accelerated pace, there is cause for optimism that widespread and lasting immunity can be achieved through COVID-19 vaccination. We now have multiple safe and effective COVID-19 vaccines with unique advantages that are authorised for use in Canada. Vaccine coverage is increasing across Canada, with benefits being seen in prioritized high-risk populations. Ramp up of vaccine supply and acceleration of vaccination programs will return further benefits to protect more Canadians, over the coming weeks and months.

However, with the ongoing increase in COVID-19 activity over several weeks and a rising proportion of cases that involve more contagious variants of concern, strong public health measures and individual precautions must be sustained where COVID-19 is circulating. The latest national-level data show a 7-day average of 5,194 new cases daily (Mar 26-Apr 1). Sustained high infection rates are also impacting lagging indicators of COVID-19 severity, which are levelling off (deaths) or increasing (hospitalisation), particularly in areas with elevated disease activity. The rise in severe and critical illnesses is placing renewed strain on the health system and healthcare workforce. Provincial and territorial data indicate that an average of 2,394 people with COVID-19 were being treated in Canadian hospitals each day during the most recent 7-day period (Mar 26-Apr 1), including 700 of whom were being treated in intensive care units. During the same period, there were an average of 30 COVID-19-related deaths reported daily. While this lagging severity indicator has levelled off, there is a concern that trend could also shift if the increase in severe illness trends persists.

While COVID-19 continues to impact people of all ages in Canada, infection rates are highest among those aged 20-39 years of age. Although severe illness is less common among young adults, it is important to remember that serious illness can occur at any age and evidence indicates that variants of concern can be associated with more severe illness and increased risk of death. In addition, circulation of COVID-19 in younger, more mobile and socially-connected adults presents an ongoing risk for spread into high-risk populations and settings. The emergence and spread of certain SARS-CoV-2 virus variants heightens this concern. For the week of March 21-27, there were on average of 108, 801 tests completed daily across Canada, of which 4.3% were positive for COVID-19. As of April 1, a total of 11,652 variant of concern cases have been reported across Canada, including 10,856 involving B.1.1.7 variants, 483 P.1 variants and 313 B.1.351 variants.

Amid the concerning trends of increasing disease activity, shifting severity trends, and a rising proportion of cases involving variants of concern, a high degree of caution must be maintained, while vaccination programs continue to accelerate. Any easing of public health measures must be done slowly,informed by an assessment of key indicators and local circumstances, and accompanied by enhanced testing, screening, and genomic analysis to detect and respond to variants of concern quickly. In particular, there must be sufficient contact tracing capacity and supports for effective isolation, given increased transmissibility of variants of concern.

Canadians are urged to remain vigilant, continue following local public health advice, and consistently maintain individual practices that keep us and our families safer: stay home/self-isolate if you have any symptoms, think about the risks and reduce non-essential activities and outings to a minimum, avoid all non-essential travel, and maintain individual protective practices of physical distancing, hand, cough and surface hygiene and wearing a well-fitted and properly worn face mask as appropriate (including in shared spaces, indoors or outdoors, with people from outside of your immediate household).

Aiming to have the fewest interactions with the fewest number of people, for the shortest time, at the greatest distance possible, while wearing the best-fitting mask is a simple rule that we can all apply to help limit the spread of COVID-19, as vaccine programs expand to protect all Canadians.

Canadians can also go the extra mile by sharing credible information on COVID-19 risks and prevention practices and measures to reduce COVID-19 in communities and by downloading the COVID Alert app to break the cycle of infection and help limit the spread of COVID-19. Read my backgrounder to access more COVID-19 Information and Resources on ways to reduce the risks and protect yourself and others, including information on COVID-19 vaccination.

Canadians may have additional questions regarding the risks and benefits of vaccination, given the recent safety signal related to rare but serious cases of blood clots associated with low levels of blood platelets (thrombocytopenia) following vaccination with the AstraZeneca vaccine in Europe. While this development is concerning, we can be assured that Canada is part of a strong global vaccine safety monitoring system that quickly picked up this signal. Together Canada's regulator, Health Canada, the Public Health Agency of Canada, the National Advisory Committee on Immunization and Chief Medical Officers of Health are working with experts across the country and around the world to continuously review the evolving evidence, alert health care professionals and the public on symptoms to be aware of to aid in rapid detection and treatment to mitigate this event. Canada's regulatory and health leaders are committed to working together, adapting approaches as the science and situation evolves, and providing clear and evidence-informed guidance in order to keep everyone in Canada safe and healthy.

Contacts

Media Relations
Public Health Agency of Canada
613-957-2983
hc.media.sc@canada.ca

Search for related information by keyword: Health and Safety | Public Health Agency of Canada | Canada | Coronavirus (COVID-19) | media | statements

Page details

Date modified: